Report Code: A03787 | Pages: NA | Mar 2023 | 6585 Views | ||
Author(s) : NA | Tables: NA | Charts: NA |
|
Pandemic disrupted the entire world and affected many industries.
Get detailed COVID-19 impact analysis on the Rna Interference (rnai) Drug Delivery Market
Request Now !RNA Interference (RNAi) is a biological process in which RNA molecules inhibit the gene expression. Study of RNAi helps in the analysis of gene functions in eukaryotic organisms.
The global RNAi drug delivery market is driven by several factors such as increasing research activities in the field of RNA therapeutics, growing number of academic research institutes, and increasing prevalence of chronic disorders such as cardiac abnormalities and cancer. However, high costs of research and threat of failure will restrain the market growth. Increasing research in the field of nanotechnology will provide opportunities for the market growth.
The report segments the global RNAi drug delivery market based on the type of drug delivery technology, application, and region. Based on type of drug delivery technology, it is segmented into nanoparticle drug delivery technology, pulmonary drug delivery technology, nucleic acid drug delivery technology, and aptamer drug delivery technology. Based on application it is segmented into infectious diseases, cardiology, oncology, neurology, ophthalmology, and metabolic disorders. Geographically, it has been analyzed across North America (U.S., Canada, and Mexico), Europe (Germany, France, UK, Italy, Spain, and rest of Europe), Asia-Pacific (Japan, China, India, Australia, South Korea, and rest of Asia-Pacific), and LAMEA (Brazil, Saudi Arabia, South Africa, and rest of LAMEA).
Key players that operate in the market include Tekmira Pharmaceuticals Corp., Alnylam Pharmaceuticals Inc., Merck & Co. Inc., Isis Pharmaceuticals, Inc., Access Pharmaceuticals Inc., Dicerna Pharmaceuticals Inc., Calondo Pharmaceuticals Inc., Marina Biotech Inc., RXi Pharmaceuticals Corp., and Quark Pharmaceuticals Inc.
Key Benefits
RNA Interference (RNAi) Drug Delivery Market Report Highlights
Aspects | Details |
---|---|
By Type of Drug Delivery Technology |
|
By Application |
|
By Region |
|
Key Market Players | Tekmira Pharmaceuticals Corp., Alnylam Pharmaceuticals Inc., Merck & Co. Inc.,, Isis Pharmaceuticals, Inc.,, Access Pharmaceuticals Inc., Dicerna Pharmaceuticals Inc., Calondo Pharmaceuticals Inc., Marina Biotech Inc., RXi Pharmaceuticals Corp., Quark Pharmaceuticals Inc. |
Loading Table Of Content...
Start reading.
This Report and over 19,644+ more Reports, Available with Avenue Library. T&C*.
Enterprise
License/PDF
Library
Membership
*Taxes/Fees, if applicable will be added during checkout. All prices in USD
To ensure high-level data integrity, accurate analysis, and impeccable forecasts
For complete satisfaction
On-demand customization of scope of the report to exactly meet your needs
Targeted market view to provide pertinent information and save time of readers
Get insights on topics that are crucial for your business. Stay abreast of your interest areas.
Get Industry Data AlertsTo ensure high-level data integrity, accurate analysis, and impeccable forecasts
For complete satisfaction
On-demand customization of scope of the report to exactly meet your needs
Targeted market view to provide pertinent information and save time of readers